Overview
The message reaches you before any explanation does. You open your scan or blood report and there's a line in it, the software has flagged something. "Suspicious." "Needs clinical correlation." "Follow-up advised." The report is sitting on your phone, nobody has rung you, and you find yourself reading that same sentence three times over, none the wiser. Is it a diagnosis? A warning? Or just a machine erring on the side of caution?
That gap between a flag going up and a human being explaining it is where one of the biggest safety questions in diagnostics now sits.
What an AI Flag Actually Means
An AI alert is not a diagnosis, and it's worth being clear about that from the start. All it means is that a pattern in your scan or your test result looks like the patterns the software was trained to watch for. Somebody still has to interpret it: a qualified clinician, looking at the same images or samples, but with your symptoms in front of them, and your medical history, and the quality of the image itself, and whatever other tests you've had.
Software, remember, only ever sees a thin slice of you. An X-ray shot at a slight angle can distort a reading. So can movement blur on a scan, or a sample that sat around too long before it was processed. And no algorithm knows that you had pneumonia two months back, or what your family history does to the picture. You know those things. It doesn't.
It can get it wrong both ways, too. AI can flag something that turns out to be perfectly harmless and it can stay silent about something that really matters. Regulators, by and large, understand this, which is why these tools are generally treated as decision support. Support, not the decision-maker.
The clearest evidence to date comes from breast screening and it's a useful example, because it shows AI doing the job it's actually good at. In the MASAI trial, published in *The Lancet Digital Health* in February 2025, mammography screening supported by AI, covering 105,934 women, picked up 338 cancers, compared with 262 under standard double reading. That's a 29% increase in detection, with almost half the reading workload, and no significant rise in false positives. Notice the division of labour, though: the AI triaged cases and highlighted areas; people made the call. And keep the limits in mind, this was one screening programme, running one AI system. It doesn't automatically tell you what will happen with a different test, in a different hospital.
Why the Next Step Is Where Things Break Down
The alert itself is rarely the problem. The handover after it is. A flagged result that nobody acts on can hold up a diagnosis and let's be honest, results were getting lost long before AI turned up.
A systematic review in *BMJ Quality & Safety* found follow-up failed for 20.04% to 61.6% of inpatient tests, and in one included study physicians were unaware of 61.6% of results still pending when a patient was discharged. A separate review of outpatient practices found an apparent failure to inform patients, or to document informing them, in 7.1% of clinically significant abnormal results, reaching 26.2% at the worst-performing practices.
Software brings two risks of its own, and both are well documented. The first is alert fatigue: a system that flags too much teaches clinicians to wave flags away and one day the flag they wave away is the one that mattered. The second is automation bias, something the World Health Organization warns about in plain terms. Staff may lean on a machine's output too readily, and walk straight past an error they'd have spotted on their own. None of this is theoretical: ECRI, a healthcare safety organisation, ranked AI-enabled health technologies as its number one technology hazard for 2025.
Who Is Accountable When an Algorithm Raises a Flag?
So where does accountability actually sit? With people, and with institutions not with the software. Who answers for what will vary with the country you're in, with the facility's own policies, and with how urgent the finding is. But in most systems, the duty is shared across four points.
First, the clinician. Whoever ordered the test, or is interpreting it, owns the clinical judgement does this finding fit your symptoms and your history? Is the image good enough to trust in the first place? And what, concretely, happens next?
radiologist, pathologist, or laboratory physician carries the final read on any study where AI lent a hand. That includes getting urgent findings to the right person through a proper, defined channel, rather than simply filing the report away.
The institution owns the system: who reviews each alert, how quickly, how results get escalated when they need to be, and how patients are actually contacted.
The vendor owns transparency: being straight about what the tool can do and what it can't, and about how it will be monitored once it's out in the real world.
This isn't just a question for individual hospitals, either; the wider industry is arguing about it too. Conferences such as MedTech World, which bring clinicians, device makers, and regulators together, regularly take up how AI-assisted diagnostics should be governed from validation to who owns the follow-up. If you're a patient, that debate isn't abstract. A tool is only ever as strong as the pathway that carries its findings to a doctor who acts on them.
What a Safe Follow-Up System Looks Like
Five things separate a safe follow-up service from a risky one. They aren't exotic. Most of them are ordinary organisational discipline.
Clear escalation pathways. Every alert should have a name attached to it, a time limit, and a route it follows. A critical finding should reach the clinician directly a phone call, not an email that could sit unread all weekend and it should stay clear whose job it is as care moves between lab, hospital, clinic and home.
Human review before closure. Nothing gets closed until a qualified clinician has looked at it against your history and decided on a plan. Software can shuffle the queue and tell people what to look at first. Closing a case is not its call to make.
Transparent communication. If AI played a part in producing your report, the report should tell you so, in language you can actually follow and it should tell you what the finding means, and who will be in touch with you about it.
Data protection. Images and results are sensitive, so ask how they are stored, who can get at them, and how long they're kept for. Sharing should be confined to the people caring for you, and it should be logged.
Access to follow-up care. A suspicion that nobody can investigate does harm in its own right the worry alone sees to that. Well-run services plan the referral path before they need it: repeat imaging, a specialist consultation, a biopsy. And if your hospital or lab can't arrange it, ask for the referral in writing, so you can take it somewhere else.
What You Can Do When Your Report Mentions an AI Finding
You don't have to make sense of the alert yourself, that's not your job. What you do have to do is make sure somebody qualified has made sense of it.
Ask whether a clinician has reviewed the result, or whether it is still waiting in a queue somewhere.
Ask who owns the follow-up and by when: a person's name and a timeframe, not a general assurance that someone will call.
Request the full report, including the images, and any earlier studies that could be used for comparison.
Share your context: past illnesses, surgeries, medicines, family history, previous scans. The algorithm didn't have all of that. Your clinician should.
Ask what the plan is if the finding turns out to be significant and, if it isn't, what else might explain it.
Seek a second opinion for serious findings, it's normal practice, and a good doctor won't take it as an insult.
Keep your own copy of every report and follow-up note, particularly if you move cities or change doctors.
Where the Rules Are Heading
The rules, meanwhile, are still catching up, and not at the same speed everywhere. Take the US. By September 2026 the FDA had authorised more than 1,600 AI-enabled medical devices, and getting authorised isn't the end of it any more developers now have to spell out how their algorithms will be watched, and updated, once they're live. Or take the WHO, whose 2024 guidance on generative AI in health runs to over 40 recommendations aimed at governments, developers and providers alike. It doesn't shy away from the problems, either; false and biased outputs are named there as documented risks.
India's framework points the same way, even if the documents look different. The ICMR's *Ethical Guidelines for Application of Artificial Intelligence in Biomedical Research and Healthcare* ask developers, clinicians and institutions alike to work to principles that include accountability, safety and governance, and the country's drug regulator has since published draft guidance covering medical device software. Different frameworks, different wording the underlying line doesn't change. A tool can help. It cannot carry the responsibility.
Frequently Asked Questions
Does an AI flag mean I have a disease?
No and this is the bit people find hardest to hold on to when they're staring at a flagged report at midnight. A flag means a pattern showed up that's worth a closer look, nothing more final than that. Plenty of flagged findings come to nothing. A few don't. Telling one from the other is a clinician's job, done with your symptoms, your history and your other tests in front of them not the software's, and not yours alone either.
Who is responsible if an AI-flagged result is missed?
The software can't be accountability isn't something an algorithm can hold. It sits with people, and with institutions. The clinician who ordered your test, or who interpreted it. The specialist who signed the report off. The hospital or lab whose job the follow-up was. Each of them carries defined duties, though the exact standards do vary from one country to another. And if you believe one of your results was missed? Ask for the review records. Then get a second clinical opinion.
Can I ask whether AI was used in my report?
Yes. Ask, plainly. Was software involved in the analysis? What did it flag? And has a clinician looked at it since? You don't need a special reason to ask any of that, and disclosure like this is, slowly, becoming a routine part of how reports are written.
Conclusion
Here's the simplest way to hold it. An AI alert is a prompt, a tap on the shoulder, not a verdict. It shows a doctor where to look harder. It doesn't tell you what you have, and it gets no say in what happens next. As for follow-up failures, blame rarely belongs to the algorithm alone. Look closer and you usually find something duller: a pathway nobody spelled out, a report nobody opened, an alert that belonged to nobody in particular.
And if the flagged report is yours, you're not as powerless as that moment tends to feel. Ask who reviewed it. Ask whose job the follow-up is, and by when it will happen. Keep the images, keep your earlier reports, and if the finding is serious, get that second opinion without apologizing for it. Safe diagnostics rest on systems that close the loop and, more often than the systems like to admit, on patients who keep asking whether anyone actually has.
